VHS operates a FINRA/SIPC licensed boutique investment banking firm focused on growth companies within all health care sectors including: biotechnology, branded pharmaceuticals, health care IT, diagnostics, health care services, generic pharmaceuticals, medical devices, and specialty pharmaceuticals. Our relationships and clients are national in scope and also include European, Indian, Asian, and other emerging markets. Specialties: VHS offers M&A advisory services on the sell-side and buy-side with enterprise value transactions from $10 to $500 million. We also advise companies with seeking capital including equity and all forms of debt from $10 to $100 million. Additionally, VHS offers consulting services for companies regarding business development and strategic relationships such as: in-licensing and out-licensing of products or technology, channel partners, and corporate partnering.